Search research articles
Contact Us
Filters
Showing results (11-20 of 138) with videos related to
Page
of 14
Sort By:
Basic & Clinical Pharmacology & Toxicology
|
May 9, 2019
Nebivolol in the treatment of arterial hypertension
Nasima Olawi, Marcus Krüger, Daniela Grimm, et al.
Current Pharmaceutical Design
|
February 26, 2011
Drugs interfering with apoptosis in breast cancer
Daniela Grimm, Markus Wehland, Jessica Pietsch, et al.
International Journal of Molecular Sciences
|
March 11, 2023
Latest Knowledge on the Role of Vitamin D in Hypertension
Niklas S Jensen, Markus Wehland, Petra M Wise, et al.
Nutrients
|
July 25, 2019
The Effects of Oral l-Arginine and l-Citrulline Supplementation on Blood Pressure
David Khalaf, Marcus Krüger, Markus Wehland, et al.
International Journal of Molecular Sciences
|
July 29, 2023
A Systematic Review of the Effect of Vericiguat on Patients with Heart Failure
Urjosee Sahana, Markus Wehland, Ulf Simonsen, et al.
Basic & Clinical Pharmacology & Toxicology
|
April 27, 2017
Azilsartan Medoxomil, an Angiotensin II Receptor Antagonist for the Treatment of Hypertension
Marie Hjermitslev, Daniela G Grimm, Markus Wehland, et al.
International Journal of Molecular Sciences
|
December 22, 2019
Multikinase Inhibitor Treatment in Thyroid Cancer
Ole Vincent Ancker, Marcus Krüger, Markus Wehland, et al.
International Journal of Molecular Sciences
|
May 1, 2013
Biomarkers for anti-angiogenic therapy in cancer
Markus Wehland, Johann Bauer, Nils E Magnusson, et al.
Journal of Clinical Medicine
|
January 23, 2020
The Vasoactive Mas Receptor in Essential Hypertension
Amalie L Povlsen, Daniela Grimm, Markus Wehland, et al.
Basic & Clinical Pharmacology & Toxicology
|
June 18, 2019
A focus on riociguat in the treatment of pulmonary arterial hypertension
Anne Kathrine Toxvig, Markus Wehland, Daniela Grimm, et al.
Page
of 14
Search research articles
Search
Showing results (11-20 of 138) with videos related to
Sort By:
Page
of 14
Basic & Clinical Pharmacology & Toxicology
|
May 9, 2019
Nebivolol in the treatment of arterial hypertension
Nasima Olawi, Marcus Krüger, Daniela Grimm, et al.
Current Pharmaceutical Design
|
February 26, 2011
Drugs interfering with apoptosis in breast cancer
Daniela Grimm, Markus Wehland, Jessica Pietsch, et al.
International Journal of Molecular Sciences
|
March 11, 2023
Latest Knowledge on the Role of Vitamin D in Hypertension
Niklas S Jensen, Markus Wehland, Petra M Wise, et al.
Nutrients
|
July 25, 2019
The Effects of Oral l-Arginine and l-Citrulline Supplementation on Blood Pressure
David Khalaf, Marcus Krüger, Markus Wehland, et al.
International Journal of Molecular Sciences
|
July 29, 2023
A Systematic Review of the Effect of Vericiguat on Patients with Heart Failure
Urjosee Sahana, Markus Wehland, Ulf Simonsen, et al.
Basic & Clinical Pharmacology & Toxicology
|
April 27, 2017
Azilsartan Medoxomil, an Angiotensin II Receptor Antagonist for the Treatment of Hypertension
Marie Hjermitslev, Daniela G Grimm, Markus Wehland, et al.
International Journal of Molecular Sciences
|
December 22, 2019
Multikinase Inhibitor Treatment in Thyroid Cancer
Ole Vincent Ancker, Marcus Krüger, Markus Wehland, et al.
International Journal of Molecular Sciences
|
May 1, 2013
Biomarkers for anti-angiogenic therapy in cancer
Markus Wehland, Johann Bauer, Nils E Magnusson, et al.
Journal of Clinical Medicine
|
January 23, 2020
The Vasoactive Mas Receptor in Essential Hypertension
Amalie L Povlsen, Daniela Grimm, Markus Wehland, et al.
Basic & Clinical Pharmacology & Toxicology
|
June 18, 2019
A focus on riociguat in the treatment of pulmonary arterial hypertension
Anne Kathrine Toxvig, Markus Wehland, Daniela Grimm, et al.
Page
of 14